Jason Schafer, PharmD, MPH, BCPS AQ-ID, associate professor in the Department of Pharmacy Practice at Jefferson College of Pharmacy at Thomas Jefferson University, discusses the implications of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)-containing antiretroviral therapy.
0 Comments